Role of MDR1 and MRP1 in trophoblast cells, elucidated using retroviral gene transfer.

Natural differences in expression and retroviral transduction techniques were used to test the hypothesis that MDR1 P-glycoprotein (P-gp) and MRP1 (multidrug resistance-related protein) contribute to xenobiotic handling by placental trophoblast. RT-PCR and Western blotting in placenta, primary cytotrophoblast cell cultures, and BeWo, JAr, and JEG choriocarcinoma cell lines showed that MRP1 was ubiquitously expressed, whereas MDR1 was absent or minimally expressed in BeWo and JEG cell lines. In syncytiotrophoblast, P-gp was localized predominantly to the microvillous, maternal facing plasma membrane, and MRP1 to the basal, fetal facing plasma membrane. Functional studies showed that cyclosporin A-sensitive accumulation of [3H]vinblastine by cells containing both transport proteins was significantly different from those expressing predominantly MRP1. Retroviral gene transfer of MDR1 to BeWo cells confirmed that this difference was due to the relative expression of MDR1. Therefore, both P-gp and MRP1 contribute to xenobiotic handling by the trophoblast. Localization of P-gp to the microvillous membrane suggests an essential role in preventing xenobiotic accumulation by the syncytiotrophoblast and, therefore, in protecting the fetus.

[1]  C. Sibley,et al.  Transtrophoblast and microvillus membrane potential difference in mature intermediate human placental villi. , 1993, The American journal of physiology.

[2]  G R Lankas,et al.  Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. , 1998, Reproductive toxicology.

[3]  K. Audus,et al.  Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells. , 2000, Reproductive toxicology.

[4]  O. van Tellingen,et al.  Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. , 1999, The Journal of clinical investigation.

[5]  G. Stoter,et al.  Molecular mechanisms of multidrug resistance in cancer chemotherapy. , 1996, Pathology, research and practice.

[6]  M. Flens,et al.  Tissue distribution of the multidrug resistance protein. , 1996, The American journal of pathology.

[7]  H Nakano,et al.  Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. , 2000, European journal of pharmacology.

[8]  C. Sibley,et al.  Purification and Na+ uptake by human placental microvillus membrane vesicles prepared by three different methods. , 1988, Biochimica et biophysica acta.

[9]  T. Furukawa,et al.  Function of P-glycoprotein expressed in placenta and mole. , 1997, Biochemical and biophysical research communications.

[10]  H. Kliman,et al.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. , 1986, Endocrinology.

[11]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[12]  S. Hegewisch-Becker,et al.  High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. , 1996, Blood.

[13]  P. Meier,et al.  Expression of members of the multidrug resistance protein family in human term placenta. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[15]  P. Peters,et al.  Drugs of choice in pregnancy: primary prevention of birth defects. , 1993, Reproductive toxicology.

[16]  C. K. Pearson,et al.  Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta , 1994, The Histochemical Journal.

[17]  Pasanen,et al.  The expression and regulation of drug metabolism in human placenta. , 1999, Advanced drug delivery reviews.

[18]  K Ueda,et al.  Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins. , 1990, The Journal of biological chemistry.

[19]  C. Sibley,et al.  Membrane potential difference and intracellular cation concentrations in human placental trophoblast cells in culture. , 1996, The Journal of physiology.

[20]  J. Glazier,et al.  Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta. , 1996, Molecular human reproduction.

[21]  P. Twentyman,et al.  Experimental modulation of MRP (multidrug resistance-associated protein)-mediated resistance. , 1996, European journal of cancer.

[22]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[23]  S. Cole,et al.  Function, evolution and structure of multidrug resistance protein (MRP). , 1997, Seminars in cancer biology.

[24]  K. Peng,et al.  Tissue and Cell Distribution of the Multidrug Resistance-Associated Protein (MRP) in Mouse Intestine and Kidney , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[25]  A. Swann,et al.  Major system toxicities and side effects of anticonvulsants. , 2001, The Journal of clinical psychiatry.

[26]  P. Ayuk,et al.  Syncytiotrophoblast basal plasma membrane isolation. , 1998, Placenta.

[27]  V. Ganapathy,et al.  Selective Impairment of Taurine Transport by Cyclosporin A in a Human Placental Cell Line , 1992, Pediatric Research.

[28]  A. Schinkel,et al.  The physiological function of drug-transporting P-glycoproteins. , 1997, Seminars in cancer biology.